EUVIMEDEUVIMED entdecken
Crossref

Naringin acts as a TRPV1 antagonist to attenuate UVB ‐induced senescence and damage in HaCaT cells

Ying-Jie Zhu iD, Hu-Lin Chen, Xin-Jie Cai, Bang-le Zhan, Xiao-Ming Liu

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Ying-Jie Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology & STD, Southern University of Science and Technology Hospital, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: HaCaT Cells, Matrix Metalloproteinase 9, Flavanones. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to explore the mechanism of naringin (Nar) in alleviating ultraviolet B (UVB)‐induced HaCaT cell senescence and damage. Human keratinocytes (HaCaT cells) were divided into control, UVB, UVB + Nar, UVB + Cap, and UVB + Nar + Cap groups. Analysis was performed using the MTT assay to assess cell viability, flow cytometry to measure the apoptosis level, SA‐β‐Gal staining to observe cellular senescence, and Western blot to assess protein levels of TRPV1, p16, p53, p21, matrix metalloproteinase (MMP)‐1, and MMP‐9. Both UVB irradiation and capsaicin (Cap) treatment upregulated the expression of TRPV1 in HaCaT cells, inhibited cell proliferation, promoted apoptosis, and increased the expression of p16, p53, p21, MMP‐1, and MMP‐9. Nar treatment reversed the above effects via inhibition of TRPV1 expression, thereby relieving senescence and cell damage induced by UVB irradiation. Taken together, these findings suggest that Nar can reduce UVB‐induced senescence and damage in HaCaT cells by acting as an antagonist of TRPV1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HaCaT CellsMatrix Metalloproteinase 9FlavanonesHumansTumor Suppressor Protein p53KeratinocytesApoptosisUltraviolet RaysTRPV Cation Channels

Stichwörter der Autor:innen

human keratinocytenaringin (Nar)transient receptor potential vanilloid 1 (TRPV1) antagonistultraviolet B (UVB)-induced senescence and damage

Substanzen

naringinMatrix Metalloproteinase 9Tumor Suppressor Protein p53TRPV1 protein, humanTRPV Cation ChannelsFlavanones

Autor:innen und Institutionen

  • Department of Dermatology & STD, Southern University of Science and Technology Hospital, Shenzhen, Guangdong, China.
  • Department of Dermatology & STD, Guangdong Women and Children Hospital, Guangzhou, Guangdong, China.

ORCID-Profile: Ying-Jie Zhu

Zitieren

APA

Zhu, Y. J., Chen, H. L., Cai, X. J., Zhan, B. L., & Liu, X. M. (2024). Naringin acts as a TRPV1 antagonist to attenuate UVB ‐induced senescence and damage in HaCaT cells. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14390

Vancouver

Zhu YJ, Chen HL, Cai XJ, Zhan BL, Liu XM. Naringin acts as a TRPV1 antagonist to attenuate UVB ‐induced senescence and damage in HaCaT cells. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14390

BibTeX
@article{Zhu2024,
  author = {Zhu, Ying-Jie and Chen, Hu-Lin and Cai, Xin-Jie and Zhan, Bang-le and Liu, Xiao-Ming},
  title = {Naringin acts as a TRPV1 antagonist to attenuate UVB ‐induced senescence and damage in HaCaT cells},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14390}
}
Kostenlos starten →